Equities research analysts forecast that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) will announce sales of $3.90 billion for the current quarter, according to Zacks. Six analysts have provided estimates for Teva Pharmaceutical Industries’ earnings, with the highest sales estimate coming in at $4.04 billion and the lowest estimate coming in at $3.84 billion. Teva Pharmaceutical Industries […]
